Abstract
We report the case of a male patient with Ph-positive CML who developed AML 5 years after allogeneic BMT. Clinically, the AML seemed to develop on the basis of a myelodysplasia. The myeloid origin of blasts has been proven by immunophenotyping. The variable number of tandem repeats (VNTRs) and short tandem repeat (STR) showed donor-type haemopoiesis. The interphase FISH showed the XX genotype directly in the morphologically identifiable blasts and in the CD34-positive sorted bone marrow cells. This proved the new leukaemia to be of donor origin. The necessity of using multiple techniques and the advantage of combined immunophenotyping and FISH methods in this case is emphasized.
Bone Marrow Transplantation (2002) 29, 449–452. doi:10.1038/sj.bmt.1703378
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bhatia S, Ramsay NKC, Steinbuch M et al. Malignant neoplasms following bone marrow transplantation Blood 1996 87: 3633 3639
Fialkow PJ, Thomas ED, Bryant JI et al. Leukaemic transformation of engrafted human marrow cells in vivo Lancet 1971 693: 251 255
Katz F, Reeves BR, Alexander S et al. Leukaemia arising in donor cells following allogeneic bone marrow transplantation for thalassaemia demonstrated by immunological, DNA and molecular cytogenetic analysis Br J Haematol 1993 85: 326 331
Lowsky R, Fyles G, Minden M et al. Detection of donor cell derived acute myelogenous leukaemia in a patient transplanted for chronic myelogenous leukaemia using fluorescence in situ hybridization Br J Haematol 1996 93: 163 165
Cooley LD, Sears DA, Udden MM et al. Donor cell leukemia: report of a case occurring 11 years after allogeneic bone marrow transplantation and review of the literature Am J Hematol 2000 63: 46 53
Cransac M, Boiron JM, Merel P et al. Burkitt-type acute lymphoblastic leukemia in donor cells after allogeneic bone marrow transplantation for acute nonlymphoblastic leukemia Transplantation 1993 56: 120 123
Saito Y, Uzuka Y, Sakai N et al. A Philadelphia chromosome positive acute lymphoblastic leukemia of donor origin after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase Bone Marrow Transplant 2000 25: 1209 1211
Kelemen E, Masszi T, Remenyi P et al. Reduction in the frequency of transplant-related complications in patients with chronic myeloid leukemia undergoing BMT preconditioned with a new, non-myeloablative drug combination BoneMarrow Transplant 1998 21: 747 749
Pajor L, Szuhai K, Méhes G et al. Combined metaphase, interphase cytogenetic and flow cytometric analysis of DNA content of pediatric acute lymphoblastic leukaemia Cytometry 1998 34: 87 94
Pajor L, Vass JA, Kereskai L et al. The existence of lymphoid lineage restricted Philadelphia chromosome-positive acute lymphoblastic leukemia with heterogenous bcr-abl rearrangement Leukemia 2000 14: 1122 1126
Polymeropoulos MH, Rath DS, Xiao HZ, Merril CR . Tetranucleotide repeat polymorphism at the human beta actin related pseudogene H-beta-Ac-psi-2 (ACTBP2) Nucleic Acids Res 1992 20: 1432
Dubovsky J, Daxberger H, Fritsch D et al. Kinetics of chimerism during the early post-transplant period in pediatric patients with malignant and non-malignant hematologic disorders: implications for timely detection of engraftment, graft failure and rejection Leukemia 1999 13: 2060 2069
Paloczi K . Immune reconstitution: an important component of a successful allogeneic transplantation Immunol Lett 2000 74: 177 181
Abbas KA, Lichtman AH, Pober JH . Transplantation Immunology. In: Abbas KA, Lichtman AH, Pober JH (eds) Cellular and Molecular Immunology WB Saunders Company: Philadelphia 2000 363 383
Acknowledgements
This work was partially supported by grants OTKA T 025812, 0388/2000 FKFP and 1/024/2001 Hungarian NKFP.
Author information
Authors and Affiliations
Additional information
Semmelweis University, Faculty of Health Sciences, Department of Immunology, Budapest, Hungary
Rights and permissions
About this article
Cite this article
Gopcsa, L., Barta, A., Banyai, A. et al. Acute myeloid leukaemia of donor cell origin developing 5 years after allogeneic bone marrow transplantation for chronic myeloid leukaemia. Bone Marrow Transplant 29, 449–452 (2002). https://doi.org/10.1038/sj.bmt.1703378
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703378
Keywords
This article is cited by
-
Genetics of donor cell leukemia in acute myelogenous leukemia and myelodysplastic syndrome
Bone Marrow Transplantation (2021)
-
Donor cell-derived leukemia after cord blood transplantation and a review of the literature: differences between cord blood and BM as the transplant source
Bone Marrow Transplantation (2014)
-
Donor cell leukemia after umbilical cord blood transplantation: recurrent or de novo? The importance of diagnosis for therapeutic decision making
International Journal of Hematology (2011)
-
Risks and Mechanisms of Oncological Disease Following Stem Cell Transplantation
Stem Cell Reviews and Reports (2010)
-
Donor derived malignancy following transplantation: a review
Cell and Tissue Banking (2007)